{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:45:37Z","timestamp":1790109937851,"version":"4.0.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,16]]},"DOI":"10.7759\/cureus.19632","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T16:56:02Z","timestamp":1637081762000},"source":"Crossref","is-referenced-by-count":2,"title":["Atypical Giant Suprasellar Prolactinoma Presenting With Visual Field Changes in the Absence of Symptoms of Hyperprolactinemia"],"prefix":"10.7759","author":[{"given":"Scott","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Q","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli A","year":"2005","unstructured":"Ciccarelli A, Daly AF, Beckers A. The epidemiology of prolactinomas. Pituitary. 2005, 8:3-6. 10.1007\/s11102-005-5079-0","journal-title":"Pituitary"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.8.5001","article-title":"Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up.","volume":"83","author":"Colao A","year":"1998","unstructured":"Colao A, Loche S, Cappa M, et al.. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. . J Clin Endocrinol Metab. 1998, 83:2777-80. 10.1210\/jcem.83.8.5001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.12.6215","article-title":"Pituitary Tumors in Children and Adolescents","volume":"84","author":"Lafferty AR","year":"1999","unstructured":"Lafferty AR, Chrousos GP. Pituitary Tumors in Children and Adolescents. J Clin Endocrinol Metab. 1999, 84:4317-23. 10.1210\/jcem.84.12.6215","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed S","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011, 96:273-88. 10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0912025","article-title":"Clinical practice. Prolactinomas","volume":"362","author":"Klibanski A","year":"2010","unstructured":"Klibanski A. Clinical practice. Prolactinomas. N Engl J Med. 2010, 362:1219-26. 10.1056\/NEJMcp0912025","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3670","article-title":"Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients","volume":"100","author":"Salenave S","year":"2015","unstructured":"Salenave S, Ancelle D, Bahougne T, et al.. Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients. J Clin Endocrinol Metab. 2015, 100:1177-86. 10.1210\/jc.2014-3670","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva FF","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, et al.. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006, 65:265-73. 10.1111\/j.1365-2265.2006.02562.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2019.05.010","article-title":"The role of surgery in the management of prolactinomas","volume":"30","author":"Donoho DA","year":"2019","unstructured":"Donoho DA, Laws ER Jr. The role of surgery in the management of prolactinomas. Neurosurg Clin N Am. 2019, 30:509-14. 10.1016\/j.nec.2019.05.010","journal-title":"Neurosurg Clin N Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-017-3042-5","article-title":"Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis","volume":"177","author":"Hoffmann A","year":"2018","unstructured":"Hoffmann A, Adelmann S, Lohle K, Claviez A, M\u00fcller HL. Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis. Eur J Pediatr. 2018, 177:125-32. 10.1007\/s00431-017-3042-5","journal-title":"Eur J Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0888-0","article-title":"Management of cystic prolactinomas: a review","volume":"21","author":"Nakhleh A","year":"2018","unstructured":"Nakhleh A, Shehadeh N, Hochberg I, Zloczower M, Zolotov S, Taher R, Daoud Naccache D. Management of cystic prolactinomas: a review. Pituitary. 2018, 21:425-30. 10.1007\/s11102-018-0888-0","journal-title":"Pituitary"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-011-0774-3","article-title":"Unrecognized visual field deficits in children with primary central nervous system brain tumors","volume":"107","author":"Harbert MJ","year":"2012","unstructured":"Harbert MJ, Yeh-Nayre LA, O'Halloran HS, Levy ML, Crawford JR. Unrecognized visual field deficits in children with primary central nervous system brain tumors. J Neurooncol. 2012, 107:545-9. 10.1007\/s11060-011-0774-3","journal-title":"J Neurooncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60118-atypical-giant-suprasellar-prolactinoma-presenting-with-visual-field-changes-in-the-absence-of-symptoms-of-hyperprolactinemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:39Z","timestamp":1707507399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60118-atypical-giant-suprasellar-prolactinoma-presenting-with-visual-field-changes-in-the-absence-of-symptoms-of-hyperprolactinemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.19632","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,16]]}}}